Literature DB >> 15899901

Disruption of fusion results in mitochondrial heterogeneity and dysfunction.

Hsiuchen Chen1, Anne Chomyn, David C Chan.   

Abstract

Mitochondria undergo continual cycles of fusion and fission, and the balance of these opposing processes regulates mitochondrial morphology. Paradoxically, cells invest many resources to maintain tubular mitochondrial morphology, when reducing both fusion and fission simultaneously achieves the same end. This observation suggests a requirement for mitochondrial fusion, beyond maintenance of organelle morphology. Here, we show that cells with targeted null mutations in Mfn1 or Mfn2 retained low levels of mitochondrial fusion and escaped major cellular dysfunction. Analysis of these mutant cells showed that both homotypic and heterotypic interactions of Mfns are capable of fusion. In contrast, cells lacking both Mfn1 and Mfn2 completely lacked mitochondrial fusion and showed severe cellular defects, including poor cell growth, widespread heterogeneity of mitochondrial membrane potential, and decreased cellular respiration. Disruption of OPA1 by RNAi also blocked all mitochondrial fusion and resulted in similar cellular defects. These defects in Mfn-null or OPA1-RNAi mammalian cells were corrected upon restoration of mitochondrial fusion, unlike the irreversible defects found in fzodelta yeast. In contrast, fragmentation of mitochondria, without severe loss of fusion, did not result in such cellular defects. Our results showed that key cellular functions decline as mitochondrial fusion is progressively abrogated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15899901     DOI: 10.1074/jbc.M503062200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  537 in total

1.  Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload.

Authors:  Jerome Piquereau; Fanny Caffin; Marta Novotova; Alexandre Prola; Anne Garnier; Philippe Mateo; Dominique Fortin; Le Ha Huynh; Valérie Nicolas; Marcel V Alavi; Catherine Brenner; Renée Ventura-Clapier; Vladimir Veksler; Frédéric Joubert
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

Review 2.  Mitochondrial dynamics in heart disease.

Authors:  Gerald W Dorn
Journal:  Biochim Biophys Acta       Date:  2012-03-16

3.  Mitochondria and antiviral innate immunity.

Authors:  Takumi Koshiba; Nasir Bashiruddin; Shunichiro Kawabata
Journal:  Int J Biochem Mol Biol       Date:  2011-08-15

4.  The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals.

Authors:  Anna-Maria Joseph; Peter J Adhihetty; Thomas W Buford; Stephanie E Wohlgemuth; Hazel A Lees; Linda M-D Nguyen; Juan M Aranda; Bhanu D Sandesara; Marco Pahor; Todd M Manini; Emanuele Marzetti; Christiaan Leeuwenburgh
Journal:  Aging Cell       Date:  2012-07-09       Impact factor: 9.304

Review 5.  Mitofusins and the mitochondrial permeability transition: the potential downside of mitochondrial fusion.

Authors:  Kyriakos N Papanicolaou; Matthew M Phillippo; Kenneth Walsh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

Review 6.  Role of mitofusin 2 in cardiovascular oxidative injury.

Authors:  Ming Zheng; Rui-Ping Xiao
Journal:  J Mol Med (Berl)       Date:  2010-09-08       Impact factor: 4.599

Review 7.  Mitochondrial morphology and cardiovascular disease.

Authors:  Sang-Bing Ong; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2010-07-14       Impact factor: 10.787

8.  Biophysical properties of mitochondrial fusion events in pancreatic beta-cells and cardiac cells unravel potential control mechanisms of its selectivity.

Authors:  Gilad Twig; Xingguo Liu; Marc Liesa; Jakob D Wikstrom; Anthony J A Molina; Guy Las; Gal Yaniv; György Hajnóczky; Orian S Shirihai
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-05       Impact factor: 4.249

Review 9.  Mitochondrial morphology-emerging role in bioenergetics.

Authors:  Chad A Galloway; Hakjoo Lee; Yisang Yoon
Journal:  Free Radic Biol Med       Date:  2012-09-29       Impact factor: 7.376

10.  Mitochondrial fission is required for cardiomyocyte hypertrophy mediated by a Ca2+-calcineurin signaling pathway.

Authors:  Christian Pennanen; Valentina Parra; Camila López-Crisosto; Pablo E Morales; Andrea Del Campo; Tomás Gutierrez; Pablo Rivera-Mejías; Jovan Kuzmicic; Mario Chiong; Antonio Zorzano; Beverly A Rothermel; Sergio Lavandero
Journal:  J Cell Sci       Date:  2014-04-28       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.